EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS109-16251 
Organism
Homo sapiens 
Tissue/cell
Kasumi-1 
Coordinate
chr3:183230800-183231660 
TF binding sites/motifs
Number: 1             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
RUNX1MA0002.2chr3:183231364-183231375AAACCACAGAG-6.14
Number of super-enhancer constituents: 9             
IDCoordinateTissue/cell
SE_09997chr3:183230451-183231736CD14
SE_11748chr3:183229085-183231754CD20
SE_18732chr3:183230523-183232472CD4p_CD25-_Il17-_PMAstim_Th
SE_43516chr3:183229197-183238622MM1S
SE_58323chr3:183220239-183279244Ly1
SE_60504chr3:183222014-183274594DHL6
SE_61518chr3:183220552-183274601Toledo
SE_62515chr3:183229386-183311073Tonsil
SE_67228chr3:183229197-183238622MM1S
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr3183231092183231442
chr3183231108183231340
Number: 1             
IDChromosomeStartEnd
GH03I183513chr3183230921183231850
Enhancer Sequence
CATACAAAAT GTTAGCAGTG GTTATAGATA AAGTTATTAA TTTTTTTAGA GTTTGTTGTA 60
TGACAACTTT ACTATACTGA GCATGAACAT TATAAACTCA GGAAAAAATA CGTAAAATAA 120
ACACATTATT GTGATTTTTA AAGGACGCAA TGAGAAAATA AAAGGTAAAC ACTAAAAGAG 180
CACTTACTAT AGGCCAGACT CTACATACTA ACTGTAAGAG TTACTCAATC CTCACCACAA 240
TGCCATGAAA AGGGTATCTA TTATCATCCC TGAGGAAACC AGATTCAGAG AAGTAATTTC 300
CTCAGAGACT TACAGTTAAT AAAAGATAGA AGCAAAGTTT GGACCAGTCA TCTCTGATTC 360
CAAAAATGCA TGTTTTTTAT ACTATTTCAA GCTGCTGCAG GTCACAAAAT GTGTGTGGGG 420
GACAAAGGCT TGGCAGATGC CAAACGTCAT TTGCACACGT CACTGGGTAG CTCAGATGAC 480
CTGATCTGCC CTGACACAGG AAGGACTAGC CAACAAGATG CCGGTTCCTA TTCCTGCTTG 540
GTGGCTGTTG ATGAGCAAAG AAGGAAACCA CAGAGGAGAA TCAAATCAAG TACTGAAGCT 600
CACATTTGTT AGAAGAAGCA TTGATCTTCA CTCCACCTGG CAATTCATCC ATCCAGCTAC 660
CTGTGTATGG ACCGAATGTG AATTGAGCAT GTATTTCTTT TTTTTTATTT TACTTTAAAT 720
TCTGGGACAC TCGTGCAGAA TGTGCAGGTT TGTTACATAG GTATACGTGT GCCATGGTTT 780
GCTGCACCTA TCAACCCGTC ATCTAGGTTT TAAGCCCTGC ATGCATTAGG TATTTGTCCT 840
AATACTCTTT CTCCCCTTCC 860